These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 223616)

  • 1. Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.
    Rance MJ
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):281S-286S. PubMed ID: 223616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 3. Simple in vivo tests that differentiate prototype agonists at opiate receptors.
    Cowan A
    Life Sci; 1981 Apr; 28(14):1559-70. PubMed ID: 6264252
    [No Abstract]   [Full Text] [Related]  

  • 4. History and development of mixed opioid agonists, partial agonists and antagonists.
    Martin WR
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):273S-279S. PubMed ID: 380616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 7. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discrimination in human post-addicts: agonist/antagonist opioids.
    Preston K; Bigelow G; Bickel W; Liebson I
    NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist.
    Ayres EA; Davis P; Burks TF
    Proc West Pharmacol Soc; 1990; 33():55-63. PubMed ID: 2177196
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple opiate receptors in peripheral tissue preparations.
    Wüster M; Schulz R; Herz A
    Biochem Pharmacol; 1981 Jul; 30(14):1883-7. PubMed ID: 6268113
    [No Abstract]   [Full Text] [Related]  

  • 12. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromorphine-peptide hybrids have mu receptor antagonistic and delta receptor agonistic activity on the mouse vas deferens and bind with high affinity to opioid receptors in rat brain.
    Smith CB; Medzihradsky F; Woods JH
    NIDA Res Monogr; 1986; 75():189-92. PubMed ID: 2828970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of buprenorphine on fentanyl withdrawal in rats.
    Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
    Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine.
    Tallarida RJ; Kimmel HL; Holtzman SG
    Psychopharmacology (Berl); 1997 Oct; 133(4):378-82. PubMed ID: 9372538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opiates, opioid receptors and thermoregulatory changes].
    Ovcharov R; Iakimova K
    Eksp Med Morfol; 1984; 23(4):205-10. PubMed ID: 6098438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.